IMPLANET chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 0.38
Dividend & YieldN/A€ (N/A)
Beta 1.08
Market capitalization 5.89M
Operating cash flow -2.75M
ESG Scores unknown

Company description

Implanet S.A., together with its subsidiaries, researches and develops, manufactures, and sells spinal and orthopedic implants. The company offers spinal and knee products. Its products include Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Jazz Frame, and ISS-Jazz Screw systems for posterior fixation. The company also provides knee prostheses under the Madison name. Implanet S.A. has a strategic partnership with Shanghai Sanyou Medical Co, Ltd. The company was founded in 2006 and is based in Martillac, France.

Sector: Healthcare - Industry: Medical Devices

Financial data

Financial Statements

Cashflow Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Change To Liabilities -19k 314k -858k 261k
Total Cashflows From Investing Activities -66k 12k -53k 1.57M
Net Borrowings 1.75M 3.43M 634k -2.16M
Total Cash From Financing Activities 1.73M 3.3M 3.77M 2.73M
Change To Operating Activities 307k -569k 366k 405k
Issuance Of Stock 3.11M 3.11M 3.11M 4.4M
Net Income -5.55M -3.65M -3.98M -3.09M
Change In Cash -2.76M 507k 655k 856k
Effect Of Exchange Rate 20k 7k -39k 13k
Total Cash From Operating Activities -4.44M -2.81M -3.02M -3.45M
Depreciation 481k 750k 546k 652k
Change To Account Receivables 562k 388k 200k -787k
Other Cashflows From Financing Activities -17k -138k 20k 488k
Change To Netincome -528k -1.29M -897k -1.59M
Capital Expenditures -322k -154k -100k -97k

Income Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Research Development 624k 435k 593k 754k
Income Before Tax -5.55M -3.65M -3.74M -4.6M
Net Income -5.55M -3.65M -3.98M -3.09M
Selling General Administrative 7.47M 6.63M 4.68M 6.49M
Gross Profit 2.94M 3.46M 2.01M 2.97M
Ebit -5.16M -3.61M -3.31M -4.32M
Operating Income -5.16M -3.61M -3.31M -4.32M
Interest Expense -664k -829k -1.39M -767k
Income Tax Expense
Total Revenue 6.72M 7.41M 3.89M 6.14M
Cost Of Revenue 3.78M 3.95M 1.88M 3.17M
Total Other Income ExpenseNet -395k -39k -428k -276k
Net Income From Continuing Ops -5.55M -3.65M -3.74M -4.6M
Net Income Applicable To Common Shares -5.55M -3.65M -3.98M -3.09M

Balance Sheet Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Total Liabilities 6.45M 8.21M 7.68M 13.9M
Total Stockholder Equity 2.4M 1.44M 1.02M 2.8M
Other Current Liabilities 709k 356k 195k 511k
Total Assets 8.85M 9.65M 8.7M 16.7M
Common Stock 1.71M 687k 535k 1.32M
Other Current Assets 129k
Retained Earnings -5.55M -3.65M -3.98M -3.09M
Treasury Stock -12.16M -2.93M -6.59M -3.13M
Cash 74k 372k 1.01M 1.87M
Total Current Liabilities 5.23M 6.22M 4.63M 7.93M
Other Stockholder Equity -12.16M -2.93M -6.59M -3.13M
Property, Plant, and Equipment 652k 1.18M 792k 1.45M
Total Current Assets 6.72M 7M 6.97M 8.67M
Net Tangible Assets 2.4M 1.44M 1.02M -1.28M
Net Receivables 2.67M 2.92M 2.22M 3.45M
Accounts Payable 2.4M 2.71M 1.74M 2.71M


Insider Transactions

Here are the insider transactions of stock shares related to IMPLANET:

Filer Name Transaction Text Ownership Date Filer Relation Shares
NO DATA

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to IMPLANET. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on IMPLANET

Here is the result of two systematic investment strategies applied to IMPLANET. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on IMPLANET

The following chart shows the equity curve of the two systematic investment strategies applied to IMPLANET:

IMPLANET automated entries

The systematic investment strategy that buys the first day of the month would give a performance of -67.27% on the backtest period.

Performance at glance

Performance

-67.27 %

Latent gain

-1172.99 €

Invested capital

1743.66 €

Annualized return

-16.49 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on IMPLANET

This is the result of two momentum investment strategies applied to IMPLANET. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on IMPLANET

The following chart shows all the entries opened by the momentum investment system on IMPLANET:

IMPLANET momentum entries
  • The first momentum investment strategy would give -78.88% of return on IMPLANET. That represents -3366.39€ of latent gain with 4267.66€ of employed capital.
  • The second momentum investment strategy would give -77.64% of return on IMPLANET. That represents -1939.72€ of latent gain with 2498.24€ of employed capital.
Performance at glance (1Q Momentum)

Performance

-78.88 %

Latent gain

-3366.39 €

Invested capital

4267.66 €

Annualized return

0.0 %
Performance at glance (2Q Momentum)

Performance

-77.64 %

Latent gain

-1939.72 €

Invested capital

2498.24 €

Annualized return

-21.57 %

Momentum equity curve on IMPLANET

The following chart shows the equity curve of the two momentum strategies applied to IMPLANET:

IMPLANET momentum equity

Note: the dividends potentially given by IMPLANET are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on IMPLANET

The following chart shows the employed capital evolution of the two momentum strategies on IMPLANET since the beginning:

IMPLANET

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250€, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000€.


Buy the dip strategy result on IMPLANET

Buy the dip entry openings on IMPLANET

IMPLANET

The performance achieved by the robo-advisor on IMPLANET is 0%. That represents 0.0$ of latent gain with 0.0€ of employed capital. The following chart shows IMPLANET stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of IMPLANET, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

0 %

Latent gain

0.0 €

Invested capital

0.0 €

Annualized return

0.0 %

Equity curve of the strategy applied to IMPLANET

The following chart shows the result of the investment strategy applied to IMPLANET:

IMPLANET

Note: the dividends potentially given by IMPLANET are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on IMPLANET

The following chart shows the employed capital evolution since the beginning of the investment strategy on IMPLANET:

IMPLANET

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on IMPLANET

In this section, I will compare the three previous investment strategies applied to IMPLANET.

Equity curve comparison on IMPLANET

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

IMPLANET investment strategy comparison

Employed capital comparison on IMPLANET

IMPLANET investment comparison

Performance comparison on IMPLANET

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment -67.27% -1172.99€ 1743.66€ -16.49%
Momentum 1 quarter -78.88% -3366.39€ 4267.66€ -20.54%
Momentum 2 quarters -77.64% -1939.72€ 2498.24€ -21.57%
Non-directional 0% 0.0€ 0.0€ 0.0%
Annualized return comparison

Automatic investment

-16.49 %

Momentum 1Q

-21.57 %

Momentum 2Q

-21.57 %

Non-directional

0.0 %

Correlated stocks

Here are the most positively and negatively correlated stocks with IMPLANET:

Positive correlations

Most correlated stocks this year

  • IMPLANET

  • Most correlated stocks last 3 months

  • SFK
  • VEEKO INTL
  • IMPLANET
  • GOAL RISE

  • Negative correlation

    Most negatively correlated stocks this year


    Most negatively correlated stocks last 3 months

  • WMCH GLOBAL

  • Note: The algorithm computes the probability of correlation between IMPLANET and the other stocks. There may be false positives or some missing correlated stocks. If the price of IMPLANET does not vary for 36 weeks, the correlation calculation result will be wrong.


    Company information

    Company name IMPLANET
    Country France
    City Martillac
    Address Technopole Bordeaux Montesquieu
    Phone 33 5 57 99 55 55
    Website www.implanet.com
    FullTime employees 39
    Industry Medical Devices
    Sector Healthcare
    Exchange XPAR
    Ticker ALIMP.XPAR
    Market www.euronext.com

    IMPLANET ESG Scores

    Environment scores

    Environment ESG Factors Scores
    Environment Score 0
    Peer Environment Performance unknown
    Environment Percentile unknown
    Palm Oil unknown
    Nuclear unknown
    Fur Leather unknown
    GMO unknown
    Coal unknown
    Pesticides unknown
    Animal Testing unknown

    Social scores

    Social ESG Factors Scores
    Social Score 0
    Peer Social Performance unknown
    Social Percentile unknown
    Highest Controversy unknown
    Peer Highest Controversy Performance unknown
    Adult unknown
    Gambling unknown
    Alcoholic unknown
    Tobacco unknown
    Catholic unknown
    Controversial Weapons unknown
    Small Arms unknown
    Military Contract unknown
    Peer Count unknown

    Related Controversy:


    Governance scores

    Governance ESG Factors Scores
    Governance Score 0
    Peer Governance Performance unknown
    Governance Percentile unknown

    ESG at glance
    Total ESG Scores: unknown
    Environment Score: 0
    Social Score: 0
    Governance Score: 0

    ESG Performance: unknown

    Peer Group: unknown

    Peer Esg Score Performance: unknown

    Rating Year: unknown

    Rating Month: unknown

    Max Age: unknown

    Percentile: unknown